Neurodegenerative Disease

Category

Vanderbilt’s Warren Center Inks CNS-based Drug Development Deal with ACADIA Pharmaceuticals Showcasing their “De-Risking” Model

In an effort to develop and commercialize central nervous system disorder therapies, such as Alzheimer’s disease and schizophrenia, Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (VCNDD) entered into an exclusive worldwide licensing and...

Michigan State University a Hub of Alzheimer’s Research in Western Michigan with Influence Beyond

A Michigan State University (MSU) is researching a cure for Alzheimer’s disease. Located at the MSU Grand Rapids Research Center, the Alzheimer’s Alliance conducts a series of clinical trials, connecting people who have the disease with researchers trying to stop it....

The New Chinese Alzheimer’s Drug (GV-971) Making its Way to Global Trials: Material Science or Marketing?

Is the world ready for GV-971(Oligomannate)? Because the first new approved Alzheimer’s drug in many years is coming to a clinical trial near you. Conditionally approved by China’s regulators, many in the West are skeptical. However, industry sponsor Green Valley...

Pin It on Pinterest